Utilization Of Evidence-Based Therapy For The Secondary Prevention Of Coronary Artery Disease: Predictors And Impact Of Pharmacist-Initiated Interventions

Over the past decades, secondary prevention has played a more and more important role in coronary artery disease management. Among the medications for long-term secondary prevention, antiplatelets, β-blockers, angiotensin-converting enzyme inhibitors (ACEIs), and statins were proven to be high...

Full description

Saved in:
Bibliographic Details
Main Author: Kassab, Yaman Walid
Format: Thesis
Language:English
Published: 2013
Subjects:
Online Access:http://eprints.usm.my/45262/1/Yaman%20Walid%20Kassab24.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
id my-usm-ep.45262
record_format uketd_dc
spelling my-usm-ep.452622019-08-22T08:35:21Z Utilization Of Evidence-Based Therapy For The Secondary Prevention Of Coronary Artery Disease: Predictors And Impact Of Pharmacist-Initiated Interventions 2013-07 Kassab, Yaman Walid RS1-441 Pharmacy and materia medica Over the past decades, secondary prevention has played a more and more important role in coronary artery disease management. Among the medications for long-term secondary prevention, antiplatelets, β-blockers, angiotensin-converting enzyme inhibitors (ACEIs), and statins were proven to be highly effective in reducing morbidity and mortality in coronary patients. Malaysian guidelines emphasize the continuous use of these evidence-based medications (EBMs) for long-term treatment after an acute coronary event. Despite the guideline recommendations, studies have reported an underuse of these EBMs in ACS patients. The main objectives of the current study were to: (1) quantify the prescription of EBMs at discharge following an acute coronary event and ongoing use in ambulatory care, (2) evaluate the impact of pharmacist-initiated interventions on improving the prescribing trend of secondary preventive therapies upon discharge, (3) evaluate patients’ adherence to EBMs at an average of two years after discharge, and (4) investigate the relationship between patients’ non-adherence and various predictors. This study adopted an interventional comparative methodology with three phases: pre-intervention, intervention, and follow-up phases. In the pre-intervention phase, a retrospective audit was conducted and a random sample of medical records pertaining to ACS patients admitted to Hospital Pulau Pinang during the period from January 2008 to January 2010 was chosen as the control group. 2013-07 Thesis http://eprints.usm.my/45262/ http://eprints.usm.my/45262/1/Yaman%20Walid%20Kassab24.pdf application/pdf en public phd doctoral Universiti Sains Malaysia Pusat Pengajian Sains Farmasi
institution Universiti Sains Malaysia
collection USM Institutional Repository
language English
topic RS1-441 Pharmacy and materia medica
spellingShingle RS1-441 Pharmacy and materia medica
Kassab, Yaman Walid
Utilization Of Evidence-Based Therapy For The Secondary Prevention Of Coronary Artery Disease: Predictors And Impact Of Pharmacist-Initiated Interventions
description Over the past decades, secondary prevention has played a more and more important role in coronary artery disease management. Among the medications for long-term secondary prevention, antiplatelets, β-blockers, angiotensin-converting enzyme inhibitors (ACEIs), and statins were proven to be highly effective in reducing morbidity and mortality in coronary patients. Malaysian guidelines emphasize the continuous use of these evidence-based medications (EBMs) for long-term treatment after an acute coronary event. Despite the guideline recommendations, studies have reported an underuse of these EBMs in ACS patients. The main objectives of the current study were to: (1) quantify the prescription of EBMs at discharge following an acute coronary event and ongoing use in ambulatory care, (2) evaluate the impact of pharmacist-initiated interventions on improving the prescribing trend of secondary preventive therapies upon discharge, (3) evaluate patients’ adherence to EBMs at an average of two years after discharge, and (4) investigate the relationship between patients’ non-adherence and various predictors. This study adopted an interventional comparative methodology with three phases: pre-intervention, intervention, and follow-up phases. In the pre-intervention phase, a retrospective audit was conducted and a random sample of medical records pertaining to ACS patients admitted to Hospital Pulau Pinang during the period from January 2008 to January 2010 was chosen as the control group.
format Thesis
qualification_name Doctor of Philosophy (PhD.)
qualification_level Doctorate
author Kassab, Yaman Walid
author_facet Kassab, Yaman Walid
author_sort Kassab, Yaman Walid
title Utilization Of Evidence-Based Therapy For The Secondary Prevention Of Coronary Artery Disease: Predictors And Impact Of Pharmacist-Initiated Interventions
title_short Utilization Of Evidence-Based Therapy For The Secondary Prevention Of Coronary Artery Disease: Predictors And Impact Of Pharmacist-Initiated Interventions
title_full Utilization Of Evidence-Based Therapy For The Secondary Prevention Of Coronary Artery Disease: Predictors And Impact Of Pharmacist-Initiated Interventions
title_fullStr Utilization Of Evidence-Based Therapy For The Secondary Prevention Of Coronary Artery Disease: Predictors And Impact Of Pharmacist-Initiated Interventions
title_full_unstemmed Utilization Of Evidence-Based Therapy For The Secondary Prevention Of Coronary Artery Disease: Predictors And Impact Of Pharmacist-Initiated Interventions
title_sort utilization of evidence-based therapy for the secondary prevention of coronary artery disease: predictors and impact of pharmacist-initiated interventions
granting_institution Universiti Sains Malaysia
granting_department Pusat Pengajian Sains Farmasi
publishDate 2013
url http://eprints.usm.my/45262/1/Yaman%20Walid%20Kassab24.pdf
_version_ 1747821479592984576